Researchers have been studying metastasis for more than 100 years, and only recently have we gained insight into the mechanisms by which metastatic cells arise from primary tumours and the reasons that certain tumour types tend to metastasize to specific organs. Stephen Paget's 1889 proposal that metastasis depends on cross-talk between selected cancer cells (the 'seeds') and specific organ microenvironments (the 'soil') still holds forth today. It is now known that the potential of a tumour cell to metastasize depends on its interactions with the homeostatic factors that promote tumour-cell growth, survival, angiogenesis, invasion and metastasis. How has this field developed over the past century, and what major breakthroughs are most likely to lead to effective therapeutic approaches?
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Weiss, L. Metastasis of cancer: a conceptual history from antiquity to the 1990s. Cancer Metastasis Rev. 19, 193–400 (2000).
Paget, S. The distribution of secondary growths in cancer of the breast. Lancet 1, 571–573 (1889).
Ewing, J. Neoplastic Diseases edn 6 (W. B. Saunders, Philadelphia, 1928).
Hart, I. R. & Fidler, I. J. Role of organ selectivity in the determination of metastatic patterns of the B16 melanoma. Cancer Res. 40, 2281–2287 (1980).
Sugarbaker, E. V. Cancer metastasis: a product of tumour-host interactions. Curr. Probl. Cancer 3, 1–59 (1979).
Poste, G. & Fidler, I. J. The pathogenesis of cancer metastasis. Nature 283, 139–146 (1979).
Fidler, I. J. The organ microenvironment and cancer metastasis. Differentiation 70, 498–505 (2002).
Coman, D. R., de Long, R. P. & McCutcheon, M. Studies on the mechanism of metastasis: the distribution of tumours in various organs in relation to the distribution of arterial emboli. Cancer Res. 11, 648–654 (1951).
Lucke, B. et al. Differential growth of metastatic tumours in liver and lung: experiments with rabbit V2 carcinoma. Cancer Res. 12, 734–738 (1952).
Zeidman, I., McCutcheon, M. & Coman, D. R. Factors affecting the number of tumour metastases, experiments with a transplantable mouse tumour. Cancer Res. 10, 357–364 (1950).
Zeidman, I. & Buss, J. M. Transpulmonary passage of tumour cell emboli. Cancer Res. 12, 731–737 (1952).
Fisher, E. R. & Fisher B. Recent observations on concepts of metastasis. Arch. Pathol. 83, 321–324 (1967).
Zeidman, I. Metastasis: a review of recent advances. Cancer Res. 17, 157–164 (1957).
Fisher, B. & Fisher, E. R. The organ distribution of disseminated 51Cr-labeled tumour cells. Cancer Res. 27, 412–419 (1967).
Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour emboli labeled with 125I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
Weiss, L. Metastatic inefficiency: causes and consequences. Cancer Metastasis Rev. 3, 1–24 (1986).
Fidler, I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 50, 6130–6138 (1990).
Heppner, G. Tumour heterogeneity. Cancer Res. 44, 2259–2265 (1984).
Nicolson, G. L. Generation of phenotypic diversity and progression in metastatic tumour cells. Cancer Metastasis Rev. 3, 25–42 (1984).
Foulds, L. The experimental study of tumour progression. Cancer Res. 14, 327–339 (1954).
Nowell, P. C. The clonal evolution of tumour cell populations. Science 194, 23–28 (1976).
Luria, S. E. & Delbruck, M. Mutations of bacteria from virus sensitive to virus resistance. Genetics 28, 491–511 (1943).
Cifone, M. A. & Fidler, I. J. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc. Natl Acad. Sci. USA 78, 6949–6952 (1981).
Hart, I. R. & Easty, D. Tumour cell progression and differentiation in metastasis. Semin. Cancer Biol. 2, 87–97 (1991).
Fidler, I. J. Selection of successive tumour lines for metastasis. Nature 242, 148–149 (1973).
Poste, G. Experimental systems for analysis of the malignant phenotype. Cancer Metastasis Rev. 1, 141–200 (1982).
Nicolson, G. L. Cancer metastasis: tumour cell and host organ properties important in metastasis to specific secondary sites. Biochem. Biophys. Acta 948, 175–224 (1988).
Fidler, I. J. & Kripke, M. L. Metastasis results from pre-existing variant cells within a malignant tumour. Science 197, 893–895 (1977).
Fidler, I. J. et al. Demonstration of multiple phenotype diversity in a murine melanoma of recent origin. J. Natl Cancer Inst. 67, 947–956 (1981).
Kerbel, R. S., Man, M. S. & Dexter, D. A model of human cancer metastasis: extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice. J. Natl Cancer Inst. 72, 93–108 (1984).
Talmadge, J. E., Wolman, S. R. & Fidler, I. J. Evidence for the clonal origin of spontaneous metastasis. Science 217, 361–363 (1982).
Fidler, I. J. & Talmadge, J. E. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumour cell. Cancer Res. 46, 5167–5171 (1986).
Tarin, D. et al. Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts. BMJ 288, 749–751 (1984).
Tarin, D. et al. Mechanisms of human tumour metastasis studied in patients with peritoneovenous shunts. Cancer Res. 44, 3584–3592 (1984).
Schackert, G. & Fidler, I. J. Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or the meninges of syngeneic animals. Cancer Res. 48, 3478–3484 (1988).
Simone, N. L. et al. Laser capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet. 14, 272–276 (1998).
Pasqualini, R. & Ruoslahti, E. Organ targeting in vivo using phage display peptide libraries. Nature 380, 364–366 (1996).
Uehara, H. et al. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.. J. Natl Cancer Inst. 95, 458–470 (2003).
Folkman, J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial award lecture. Cancer Res. 46, 467–743 (1986).
Liotta, L. A. Tumour invasion and metastasis — role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res. 46, 1–7 (1986).
Fisher, B. & Fisher, E. R. The interrelationship of hematogenous and lymphatic tumour cell dissemination. Surg. Gynecol. Obstet. 122, 791–797 (1966).
The intraperitoneal accumulation of transudate (watery fluid).
The process of recording (making movies of) the movements of objects that are viewed through a microsope.
- CROTON OIL
Oil that is produced from the seed of the tree Croton tiglium. It is an irritant that is used as a tumour promoter.
- PERITONEOVENOUS SHUNTS
Drainage of ascitic fluids into the jugular vein through a tube.
About this article
Cite this article
Fidler, I. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3, 453–458 (2003). https://doi.org/10.1038/nrc1098
Automated whole-slide images assessment of immune infiltration in resected non-small-cell lung cancer: towards better risk-stratification
Journal of Translational Medicine (2022)
In silico approach for the development of phenolic derivatives as potential anti-angiogenic agents against lysyl oxidase-like 2 enzyme
Future Journal of Pharmaceutical Sciences (2022)
Tumor-to-tumor metastasis: an extremely rare combination with renal cell carcinoma as the donor and a pancreatic neuroendocrine tumor as the recipient
Surgical Case Reports (2022)
Scientific Reports (2022)
Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
British Journal of Cancer (2022)